EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bis-Indole Derivatives as Dual Nuclear Receptor 4A1 (NR4A1) and NR4A2 Ligands

Srijana Upadhyay, Amanuel Esayas Hailemariam iD, Fuada Mariyam, Zahin Hafiz iD, Gregory Martin, Jainish Kothari, Evan Farkas, Gargi Sivaram, Logan Bell iD, Ronald Tjalkens, Stephen Safe iD

Biomolecules · 27.02.2024 · 14 (3) · 284

DOI: 10.3390/biom14030284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 27.02.2024. Verfasst von Srijana Upadhyay und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Physiology, Texas A&M University, College Station, TX 77843, USA. Hauptthemen laut MEDLINE: Glioblastoma. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bis-indole derived compounds such as 1,1-bis(3′-indolyl)-1-(3,5-disubstitutedphenyl) methane (DIM-3,5) and the corresponding 4-hydroxyl analogs (DIM8-3,5) are NR4A1 ligands that act as inverse NR4A1 agonists and are potent inhibitors of tumor growth. The high potency of several DIM-3,5 analogs (IC50 < 1 mg/kg/day), coupled with the >60% similarity of the ligand-binding domains (LBDs) of NR4A1 and NR4A2 and the pro-oncogenic activities of both receptors lead us to hypothesize that these compounds may act as dual NR4A1 and NR4A2 ligands. Using a fluorescence binding assay, it was shown that 22 synthetic DIM8-3,5 and DIM-3,5 analogs bound the LBD of NR4A1 and NR4A2 with most KD values in the low µM range. Moreover, the DIM-3,5 and DIM8-3,5 analogs also decreased NR4A1- and NR4A2-dependent transactivation in U87G glioblastoma cells transfected with GAL4-NR4A1 or GAL4-NR4A2 chimeras and a UAS-luciferase reporter gene construct. The DIM-3,5 and DIM8-3,5 analogs were cytotoxic to U87 glioblastoma and RKO colon cancer cells and the DIM-3,5 compounds were more cytotoxic than the DIM8-3,5 compounds. These studies show that both DIM-3,5 and DIM8-3,5 compounds previously identified as NR4A1 ligands bind both NR4A1 and NR4A2 and are dual NR4A1/2 ligands.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaHumansLigandsNuclear Receptor Subfamily 4, Group A, Member 1Cell Line, TumorIndolesNuclear Receptor Subfamily 4, Group A, Member 2

Stichwörter der Autor:innen

NR4A1NR4A2bis-indoledual binding

Substanzen

LigandsNuclear Receptor Subfamily 4, Group A, Member 1IndolesNR4A2 protein, humanNuclear Receptor Subfamily 4, Group A, Member 2NR4A1 protein, human

Autor:innen und Institutionen

  • Department of Veterinary Physiology, Texas A&M University, College Station, TX 77843, USA.
  • Department of Chemical Engineering, Texas A&M University, College Station, TX 77843, USA.
  • Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA.
  • Department of Chemistry, University of La Verne, La Verne, CA 91750, USA.
  • Department of Environmental and Radiological Health Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80526, USA.

ORCID-Profile: Amanuel Esayas Hailemariam, Zahin Hafiz, Logan Bell, Stephen Safe

Förderung

  • NIH HHS
  • NCI NIH HHS
  • NIEHS NIH HHS
  • NINDS NIH HHS
  • AgriLife Research
  • National Institutes of Health
  • Houston Methodist Research Institute
  • Department of Defense

Zitieren

APA

Upadhyay, S., Hailemariam, A. E., Mariyam, F., Hafiz, Z., Martin, G., Kothari, J., Farkas, E., Sivaram, G., Bell, L., Tjalkens, R., & Safe, S. (2024). Bis-Indole Derivatives as Dual Nuclear Receptor 4A1 (NR4A1) and NR4A2 Ligands. Biomolecules, 14(3), 284. https://doi.org/10.3390/biom14030284

Vancouver

Upadhyay S, Hailemariam AE, Mariyam F, Hafiz Z, Martin G, Kothari J, et al. Bis-Indole Derivatives as Dual Nuclear Receptor 4A1 (NR4A1) and NR4A2 Ligands. Biomolecules. 2024;14(3):284. doi:10.3390/biom14030284

BibTeX
@article{Upadhyay2024,
  author = {Upadhyay, Srijana and Hailemariam, Amanuel Esayas and Mariyam, Fuada and Hafiz, Zahin and Martin, Gregory and Kothari, Jainish and Farkas, Evan and Sivaram, Gargi and Bell, Logan and Tjalkens, Ronald and Safe, Stephen},
  title = {Bis-Indole Derivatives as Dual Nuclear Receptor 4A1 (NR4A1) and NR4A2 Ligands},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {3},
  pages = {284},
  doi = {10.3390/biom14030284}
}
Kostenlos starten →